HCW Biologics issues 400,000 pre-funded warrants in $1.6 million private placement

• HCW Biologics priced a $1.6 million private placement with 618,682 units tied to common stock purchase warrants.
• Deal includes 400,000 pre-funded warrants exercisable immediately at USD 0.0001 per share, with no expiration until fully exercised.
• Investors will receive common warrants to buy up to 618,682 shares, subject to stockholder approval; exercise price USD 2.59, term 5.5 years.
• Registration rights agreement calls for an S-1 filing within 15 trading days of closing to register resale shares, including warrant shares.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. HCW Biologics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607290906PRIMZONEFULLFEED9800209) on July 29, 2026, and is solely responsible for the information contained therein.